Latent Autoimmune Diabetes of Adults

It's an autoimmune form of diabetes that's comparable to T1D, but patients with LADA often have insulin resistance, which is similar to T2D, and they share several risk factors for the illness. According to studies, LADA patients develop antibodies against insulin-producing cells, and these cells quit releasing insulin at a slower rate than T1D patients. T1D and T2D appear to have genetic risk factors in common, although LADA is genetically separate from both. There is genetic and phenotypic heterogeneity within the LADA patient population, with variable degrees of insulin resistance and autoimmunity. LADA can thus be regarded as a hybrid type of T1D and T2D, with clinical and genotypic parallels to both, as well as variance within LADA in terms of autoimmunity and insulin resistance, based on current information.

    Related Conference of Latent Autoimmune Diabetes of Adults

    May 09-10, 2024

    10th Global Summit on Plant Science

    Barcelona, Spain
    June 13-14, 2024

    19th World Bioenergy Congress and Expo

    Rome, Italy
    June 13-14, 2024

    3rd World Congress on Endocrinology & Diabetes

    Rome, Italy
    June 24-25, 2024

    12th International Conference on Green Energy

    Paris, France
    August 21-22, 2024

    12th Global Summit and Expo on Pollution Control

    Paris, France
    September 11-12, 2024

    19th World Convention on Waste Recycling and Reuse

    Amsterdam, Netherlands
    September 11-12, 2024

    21st World Congress and Expo on Recycling

    Amsterdam, Netherlands
    September 23-24, 2024

    5th Global Summit on Environmental Health

    Amsterdam, Netherlands
    October 14-15, 2024

    3rd World Congress on Climate change and Ecosystem

    Madrid, Spain

    Latent Autoimmune Diabetes of Adults Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in